Novel retinal lesion seen in some ebola survivors

June 15, 2017

(HealthDay)—A small percentage of Ebola virus disease (EVD) survivors have a novel retinal lesion, according to research published in the July issue of the U.S. Centers for Disease Control and Prevention's Emerging Infectious Diseases.

Paul J. Steptoe, M.B.Ch.B., from the University of Liverpool in the United Kingdom, and colleagues conducted a case-control study in Freetown, Sierra Leone, to examine ocular signs in survivors of EVD. Ophthalmic examination, including widefield retinal imaging, was performed in 82 EVD survivors with ocular symptoms and 105 controls from asymptomatic civilian and military personnel and symptomatic eye clinic attendees.

The researchers found that Snellen visual acuity was ≤6/7.5 in 75.6 and 75.5 percent of EVD survivors and controls, respectively. Unilateral white cataracts were seen in 7.4 and 0 percent of EVD survivors and controls, respectively. In two EVD survivors with cataract but no anterior chamber inflammation, the aqueous humor was polymerase chain reaction-negative for Zaire Ebola virus, allowing surgery to be performed. In 14.6 percent of EVD survivors and no controls there was a novel retinal lesion following anatomical distribution of the optic nerve axons.

"We have documented a novel retinal abnormality in EVD survivors that appears to be specific to EVD, although the proportion in the cohort with the condition is small," the authors write.

Explore further: Ebola survivors have a 'unique' retinal scar

More information: Abstract/Full Text

Related Stories

Ebola survivors have a 'unique' retinal scar

May 15, 2017
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.

Vision impairment and eye diseases continue to be concerns for Ebola survivors

January 16, 2017
The acute outbreak of Ebola virus disease (EVD) has subsided in West Africa, but the medical community continues to learn about long-term complications for survivors – including the potential for blinding eye disease. One ...

Ebola may leave some survivors blind

May 5, 2016
(HealthDay)—About one-fifth of Ebola survivors in Sierra Leone developed severe or total vision loss within weeks of being declared free of the virus, a new study finds.

Young CA survivors more often have cost-related nonadherence

June 9, 2017
(HealthDay)—Survivors of adolescent and young adult cancer are more likely to report cost-related medication nonadherence, according to a study published online May 23 in Cancer.

Improving treatments for post-Ebola syndrome sufferers

April 12, 2016
Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week.

Post-Ebola syndrome in Sierra Leone

February 25, 2016
Researchers from the University's Institute of Translational Medicine have conducted a study of Ebola survivors to describe the medical problems they continue to have after recovering from the acute disease. The results of ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.